eglumetad has been researched along with strontium in 1 studies
| Studies (eglumetad) | Trials (eglumetad) | Recent Studies (post-2010) (eglumetad) | Studies (strontium) | Trials (strontium) | Recent Studies (post-2010) (strontium) |
|---|---|---|---|---|---|
| 190 | 5 | 48 | 6,180 | 121 | 1,694 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capogna, M; Karayannis, T; Pál, BZ; Price, CJ | 1 |
1 other study(ies) available for eglumetad and strontium
| Article | Year |
|---|---|
Group II and III mGluRs-mediated presynaptic inhibition of EPSCs recorded from hippocampal interneurons of CA1 stratum lacunosum moleculare.
Topics: Amino Acids; Aminobutyrates; Analysis of Variance; Animals; Animals, Newborn; Bridged Bicyclo Compounds; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Interneurons; Neural Inhibition; Perforant Pathway; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Strontium; Tetrodotoxin; Time Factors; Xanthenes | 2005 |